.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Citi
Deloitte
Fuji
Daiichi Sankyo
Merck
AstraZeneca
McKinsey
Federal Trade Commission

Generated: November 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078949

« Back to Dashboard
NDA 078949 describes BUDESONIDE, which is a drug marketed by Amneal Pharms, Apotex Inc, Impax Labs Inc, Mylan, Teva Pharms, Mayne Pharma, Alvogen Malta, Zydus Pharms Usa Inc, Sciecure Pharma Inc, Teva Pharms Usa, Sandoz Inc, Appco Pharma Llc, and Barr Labs Div Teva, and is included in fourteen NDAs. It is available from thirty suppliers. Additional details are available on the BUDESONIDE profile page.

The generic ingredient in BUDESONIDE is budesonide. There are twenty drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the budesonide profile page.

Summary for 078949

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Inflammatory Bowel Disease Agents
Respiratory Tract Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 078949

Medical Subject Heading (MeSH) Categories for 078949

Suppliers and Packaging for NDA: 078949

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BUDESONIDE
budesonide
SPRAY, METERED;NASAL 078949 ANDA Walgreens 0363-0048 0363-0048-01 1 BOTTLE, SPRAY in 1 BOTTLE, SPRAY (0363-0048-01) > 120 SPRAY, METERED in 1 BOTTLE, SPRAY
BUDESONIDE
budesonide
SPRAY, METERED;NASAL 078949 ANDA Rugby Laboratories 0536-1112 0536-1112-40 1 BOTTLE, SPRAY in 1 CARTON (0536-1112-40) > 60 SPRAY, METERED in 1 BOTTLE, SPRAY

Summary for product number 002

Active Rx/OTC/Discontinued:OTCDosage:SPRAY, METERED;NASALStrength0.032MG/SPRAY
Approval Date:Nov 20, 2015TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
McKesson
AstraZeneca
Citi
Medtronic
Fuji
Deloitte
Farmers Insurance
Cerilliant
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot